Related references
Note: Only part of the references are listed.Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma
Wilko Weichert et al.
CURRENT OPINION IN PULMONARY MEDICINE (2014)
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinornas: patient outcome, interplay with morphology and immunophenotype
Arne Warth et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases
Arne Warth et al.
HISTOPATHOLOGY (2014)
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Mark G. Kris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients
Youngwook Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Multicenter ALK Testing in Non-Small-Cell Lung Cancer: Results of a Round Robin Test
Maximilian von Laffert et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Molecular pathology of lung cancer. State of the art 2014
A. Warth et al.
PATHOLOGE (2014)
Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin- fixed paraffin- embedded tissues
Rita Casadonte et al.
PROTEOMICS (2014)
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
Lynnette Fernandez-Cuesta et al.
NATURE COMMUNICATIONS (2014)
Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study
Mariam Jamal-Hanjani et al.
PLOS BIOLOGY (2014)
Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas
Alexis B. Cortot et al.
EUROPEAN RESPIRATORY REVIEW (2014)
Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction?
Klaus Pantel et al.
CANCER RESEARCH (2013)
Molecular diagnostics in pathology
A. Stenzinger et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2013)
Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma
Mathieu Lederlin et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Randomized International Phase III Trial of ERCC1 and RRM1 Expression-Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non-Small-Cell Lung Cancer
Gerold Bepler et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
ERCC1 and RRM1: Ready for Prime Time?
Benjamin Besse et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistant Disease
Kadoaki Ohashi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
ALK in Lung Cancer: Past, Present, and Future
Alice T. Shaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Molecular Diagnostic Profiling of Lung Cancer Specimens with a Semiconductor-Based Massive Parallel Sequencing Approach Feasibility, Costs, and Performance Compared with Conventional Sequencing
Volker Endris et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Epidermal Growth Factor Receptor Inhibition in Lung Cancer Status 2012
Fred R. Hirsch et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROSI gene rearrangement after treatment with crizotinib
M. Bos et al.
LUNG CANCER (2013)
Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): Results of a multi-centre ALK-testing
Maximilian V. Laffert et al.
LUNG CANCER (2013)
ERCC1 Isoform Expression and DNA Repair in Non-Small-Cell Lung Cancer
Luc Friboulet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Novel morphological and molecular aspects of lung cancer
A. Warth et al.
PATHOLOGE (2013)
Association between TYMS Expression and Efficacy of Pemetrexed-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
Ting Wang et al.
PLOS ONE (2013)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
Assessment of thymidylate synthase expression in biopsy specimens and corresponding resection specimens of non-small-cell lung cancer
Esther Herpel et al.
HISTOPATHOLOGY (2012)
Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies
Arne Warth et al.
HISTOPATHOLOGY (2012)
The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival
Arne Warth et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
D. Ross Camidge et al.
LANCET ONCOLOGY (2012)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer et al.
NATURE GENETICS (2012)
Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies
Arne Warth et al.
VIRCHOWS ARCHIV (2012)
Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
Kazuya Taniguchi et al.
CLINICAL CANCER RESEARCH (2011)
Prognostic Role of ERCC1 in Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
Joshua A. Roth et al.
CLINICAL LUNG CANCER (2011)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Mass spectrometry-based clinical proteomics profiling: current status and future directions
Peter Findeisen et al.
EXPERT REVIEW OF PROTEOMICS (2009)
Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small-Cell Lung Cancer
Craig Reynolds et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA)
H. Kimura et al.
BRITISH JOURNAL OF CANCER (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy
O Gautschi et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients
M Beau-Faller et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Share Paper
